CARLSBAD, Calif. & BURLINGTON, Ontario–(BUSINESS WIRE)–The following is a letter addressed to shareholders from the Chief Executive Officer of Anaergia Inc. (TSX: ANRG) (OTCQX: ANRGF): Dear Fellow Shareholders, Since I assumed the role of Chief Executive Officer on July 8, 2024, Anaergia has undergone a period of substantial transformation and renewed momentum. Over the past year, we have refocused the business, strengthened our financial foundation, and executed on a strategy that is deliver
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
